'On consolidated basis

Quarter ended December 2024 compared with Quarter ended December 2023.

Net sales (including other operating income) of Alkem Laboratories has increased 1.52% to Rs 3374.28 crore.  Operating profit margin has jumped from 21.29% to 22.51%, leading to 7.32% rise in operating profit to Rs 759.39 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 25.27% to 26.47%.   Purchase of finished goods cost fell from 13.89% to 11.38%.   Employee cost increased from 17.24% to 17.90%.   Other expenses rose from 22.29% to 22.51%.   

Other income fell 0.69% to Rs 92.99 crore.  PBIDT rose 6.38% to Rs 852.38 crore.  Provision for interest rose 41.52% to Rs 36.03 crore.  

PBDT rose 5.23% to Rs 816.35 crore.  Provision for depreciation rose 22.60% to Rs 85.28 crore.  

Profit before tax grew 3.52...

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation